Janssen Biotech Inc.

02/16/2023 | Press release | Distributed by Public on 02/16/2023 07:26

Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in[...]